Symptomtext
A 14 day old infant was erroneously administered ActHIB today, 18May2022 on the right thigh; Initial information received on 18-May-2022 regarding an unsolicited valid non-serious case received from a other health professional via call center. This case involves a 14 days old male patient who was erroneously administered acthib today,18may2022 on the right thigh while receiving vaccine HIB (PRP/T) VACCINE [ACT-HIB]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included pneumococcal vaccine conj 13v (crm197) (Prevnar 13) for immunisation; and diphtheria vaccine toxoid, hepatitis b vaccine rhbsag (yeast), pertussis vaccine acellular 3-component, polio vaccine inact 3v (vero), tetanus vaccine toxoid (Pediarix) for Immunisation. On 18-May-2022, the patient received a 0.5 ml dose of suspect HIB (PRP/T) Vaccine (batch lot :UJ614AB)(Expiry date :12-Mar-2023)(unknown strength and formulation) via unknown route in the right thigh for immunization. On 18-May-2022 (latency : same day) the patient developed a non-serious event of a 14 day old infant was erroneously administered acthib today, 18may2022 on the right thigh (product administered to patient of inappropriate age) following the administration of HIB (PRP/T) VACCINE. Action taken : not applicable. At time of reporting, the outcome was Unknown for the event . This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.